ArticleChemistry & biodiversity2026
Comprehensive Metabolite Profiling and Enzyme Inhibitory Potential of Psidium guajava L. Hydro Alcoholic Extract: An In vitro and In Silico Approach.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Psidium guajava L. is traditionally used for gastrointestinal issues, along with its use in lowering blood glucose. The present study evaluates the phytochemical composition, in vitro antioxidant potential, and antidiabetic properties of P. guajava L. hydro alcoholic extract (PGHE). TPC and TFC were quantified from PGHE. LC-ESI-QTOF-MS/MS and HPTLC were used for metabolite profiling. In vitro antioxidant, enzyme inhibition assays, and in silico molecular interactions were investigated for PGHE. The yield of extract was 6.16%. It exhibited high phenolic (147.2 ± 0.98 mg GAE/g) and flavonoid content (70 ± 1.67 mg QUE/g). HRLC-ESI-QTOF-MS/MS profiling tentatively identified 555 metabolites, with some bioactive compounds, that is, myricetin, quercetin, ellagic acid, and gallic acid. In vitro antioxidant assays showed potent radical scavenging activity, although lower than the standard antioxidant ascorbic acid. Enzyme inhibition assays revealed PGHE's α-glucosidase and α-amylase inhibition with IC
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.